Francisco Balzarotti (born 1983 in Buenos Aires) is an Argentine scientist known for his work in super-resolution microscopy, particularly the MINFLUX method, and a group leader at the Research Institute of Molecular Pathology in Vienna. He studied electrical engineering at the University of Buenos Aires from 2002 to 2007 and took his PhD in electrical engineering in 2012 on nanophotonics, optical nanolithography, superlenses and plasmonics. As a postdoctoral researcher in the Department of NanoBiophotonics at the Max Planck Institute for Biophysical Chemistry in Göttingen, led by the Nobel laureate Stefan Hell, he played a central role in developing MINFLUX, which Physics World named its Breakthrough of the Year in 2017. The method reaches nanometer resolution with far fewer photons than earlier localization techniques. Since 2020 he has led the Advanced Microscopy and Biophysics group in Vienna, supported by the European Research Council.
Facts
Field
Field (category) Connections
Member Of
Source Francisco Balzarotti (Wikipedia)
Works In
Source Francisco Balzarotti (Wikipedia)
In the Other Atlases
Nationality
Also in Geography Atlas: the nationality of this subject.
Source Francisco Balzarotti (Wikipedia)Lead, nationalityQuote, Lead, nationality
is an Argentinian scientist
Sources
1. Francisco Balzarotti (Wikipedia)
Lead
born in 1983 in Buenos Aires, Argentina
Lead, field
known for his work in super-resolution microscopy, particularly MINFLUX
Lead, gender
He is a Group Leader at the Research Institute of Molecular Pathology
Lead, nationality
is an Argentinian scientist
Works In: Optics, Career and research
super-resolution microscopy method MINFLUX
In Group: Atomic, Molecular And Optical Physics, Career and research
MINFLUX combines elements of information theory with the single-emitter nature of PALM/STORM and the beam geometries typically used in STED
Member Of: Max Planck Society, Career and research
Department of NanoBiophotonics at the Max Planck Institute for Biophysical Chemistry
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.